For widespread, symptomatic, or refractory lichen planus, systemic corticosteroids are generally considered the first-line treatment. They provide rapid anti-inflammatory and immunosuppressive effects, leading to significant improvement in pruritus and skin lesions. While methotrexate, cyclosporine, and oral retinoids (e.g., acitretin) are effective systemic agents for lichen planus, they are typically reserved for cases that are resistant to corticosteroids, for steroid-sparing purposes, or when corticosteroids are contraindicated. Topical corticosteroids are the first-line for localized disease, but for generalized disease, systemic therapy is needed.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.